- Trials with a EudraCT protocol (113)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
113 result(s) found for: Physiological conditions.
Displaying page 1 of 6.
EudraCT Number: 2008-003367-40 | Sponsor Protocol Number: 2007/049/HP | Start Date*: 2009-03-03 |
Sponsor Name:CHU de Rouen | ||
Full Title: Pilot study of the effect of a substance P antagonist, aprepitant, on aldosterone and cortisol secretions in healthy volunteers | ||
Medical condition: The aim is to measure plasma aldosterone and cortisol concentrations in basal conditions and in response to different stimulation tests of the adrenal function | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000821-30 | Sponsor Protocol Number: SAD13-ER1 | Start Date*: 2013-07-12 |
Sponsor Name:Enrique Rey Díaz-Rubio | ||
Full Title: CLINICAL RESPONSE TO 5HT4 RECEPTORS AGONIST (PRUCALOPRIDE): GASTROCOLIC REFLEX | ||
Medical condition: chronic constipation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000324-19 | Sponsor Protocol Number: DDDCF14 | Start Date*: 2014-09-18 |
Sponsor Name:KU Leuven - Drug Delivery & Disposition | ||
Full Title: Collection and characterization of gastrointestinal fluids in different populations and conditions | ||
Medical condition: healthy human volunteers (administration of a proton-pump inhibitor) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-006237-42 | Sponsor Protocol Number: 39085 | Start Date*: 2012-12-12 |
Sponsor Name:Erasmus University Rotterdam | ||
Full Title: Optimization of exercise therapy in type 2 diabetes mellitus | ||
Medical condition: Insulin resistance, endothelial dysfunction, cardiovascular fitness, cardio-respiratory responses, glycemic control in deconditioned non-insulin dependent type 2 diabetes patients | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004943-35 | Sponsor Protocol Number: 5122016 | Start Date*: 2017-03-01 |
Sponsor Name:Radboud University Medical Center | ||
Full Title: Stimulation of ADH independent urine concentration in healthy volunteers | ||
Medical condition: healthy volunteers; the information of this pilot study will be used in the care of patients with diabetes insipidus | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002602-39 | Sponsor Protocol Number: 1562016 | Start Date*: 2016-10-25 |
Sponsor Name:Radboud University Medical Center | ||
Full Title: FGF23 response in hypophosphatemia | ||
Medical condition: healthy volunteers the information of this pilot study will be used in the care of patients with hypophosphatemia due to renal phosphate wasting | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002239-33 | Sponsor Protocol Number: CRHMOT2014 | Start Date*: 2014-10-14 |
Sponsor Name:TARGID, KU Leuven | ||
Full Title: The effect of corticotrophin-releasing hormone (CRH) on esophageal motility in healthy volunteers | ||
Medical condition: Changes in esophageal motility induced by CRH-administration | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002703-28 | Sponsor Protocol Number: DDD15POSA | Start Date*: 2015-08-06 |
Sponsor Name:KU Leuven - Drug Delivery & Disposition | ||
Full Title: Gastrointestinal Behavior of Posaconazole in Healthy Volunteers | ||
Medical condition: • Administering one tablet of Noxafil with a glass of 240 ml of water • Administering four tablets of Noxafil with a glass of 240 ml of water • Administering one tablet of Noxafil with a glass of 2... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-000434-21 | Sponsor Protocol Number: LP1 | Start Date*: 2005-06-15 |
Sponsor Name:Kognitive Neurologie, Institut für Medizin, Forschungszentrum Jülich | ||
Full Title: Neurochemische Modulation von Exekutiv- und Gedächtnisfunktionen | ||
Medical condition: Progressive cognitive decline in physiological aging | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001683-22 | Sponsor Protocol Number: 1/2011AITT | Start Date*: 2011-06-10 |
Sponsor Name:University of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy | ||
Full Title: Reversal of residual rocuronium neuromuscular block using sugammadex: a prospective, dobule-blind, randomized, controlled, dose-finding study | ||
Medical condition: The effect of sugammadex dose on residual neuromuscular blockade will be investigated, therefore patients suffering from various conditions undergoing surgery in general anaesthesia with muscle rel... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004666-34 | Sponsor Protocol Number: AITT2014/1 | Start Date*: 2014-03-17 |
Sponsor Name:University of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy | ||
Full Title: Reversal of vecuronium induced residual neuromuscular block using sugammadex: a prospective, dobule-blind, randomized, controlled, dosefinding study | ||
Medical condition: The effect of sugammadex dose on residual neuromuscular blockade will be investigated, therefore patients suffering from various conditions undergoing surgery in general anaesthesia with muscle rel... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004766-15 | Sponsor Protocol Number: MK-0518B-254 | Start Date*: 2015-05-04 |
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | ||
Full Title: MK-518B Food Effect Study | ||
Medical condition: N/A | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2013-002214-13 | Sponsor Protocol Number: IIBSP-OXI-2013-62 | Start Date*: 2013-10-28 |
Sponsor Name:Institut de Recerca de l?Hospital de la Santa Creu i Sant Pau ? IIB Sant Pau | ||
Full Title: Evaluation of oxidative stress associated with the administration of two different concentrations of oxygen for the maintenance of general anesthesia | ||
Medical condition: General anesthesia and oxidative stress | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003104-20 | Sponsor Protocol Number: Rimona2011 | Start Date*: 2011-10-06 |
Sponsor Name:UZLeuven | ||
Full Title: The effect of Acomplia® (rimonabant) on esophageal sensitivity and gastric accommodation during food intake in healthy volunteers: a single-blind, placebo-controlled study | ||
Medical condition: study is conducted on healthy volunteers, no medical condition is investigated | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-003623-23 | Sponsor Protocol Number: can.clo.ris.fMRI | Start Date*: 2008-09-17 |
Sponsor Name:Academisch medisch centrum, department of psychiatry | ||
Full Title: Effect of different antipsychotic medication on craving related brain activity in patients with schizophrenia and cannabis abuse or dependence: a randomized controlled study comparing clozapine and... | ||
Medical condition: A randomized controlled trial comparing the effect of clozapine and risperidone on cannabis craving in cannabis abusing or dependent patients with schizophrenia. Specific cognitive tasks will be us... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001009-26 | Sponsor Protocol Number: DDD19GISAM | Start Date*: 2019-09-10 |
Sponsor Name:KU Leuven - Drug Delivery and Disposition | ||
Full Title: Gastrointestinal behaviour of mesalazine in healthy volunteers | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-000958-56 | Sponsor Protocol Number: 2019/375 | Start Date*: 2019-08-16 |
Sponsor Name:Helse Fonna | ||
Full Title: “Haemodynamic stability during induction of general anesthesia with propofol and remifentanil: A randomized, controlled, double-blind study comparing low vs high propofol doses.” | ||
Medical condition: In daily clinical work we observe a hypotensive effect and a reduction in HR when induction of general anesthesia is performed using propofol and remifentanil. It is difficult to differentiate the ... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002094-22 | Sponsor Protocol Number: 2013MM002B | Start Date*: 2013-08-29 | |||||||||||
Sponsor Name:Royal Brompton and Harefield NHS Foundation Trust (RB&HFT) | |||||||||||||
Full Title: Comparison of ultra-low-dose Oral versus Transdermal Hormone Therapy on coagulation activation and metabolic risk factors for Cardiovascular Disease | |||||||||||||
Medical condition: The effect of oestrogen replacement therapy taken either orally or transdermally and observing any likely benefit of both these therapies on the risks Venous thromobembolic events and cardiovascul... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000259-14 | Sponsor Protocol Number: 1/2012AITT | Start Date*: 2012-08-31 |
Sponsor Name:University of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy | ||
Full Title: Reversal of residual pipecuronium neuromuscular block using sugammadex: a randomized, double-blind, placebo controlled, dosefinding study | ||
Medical condition: The effect of sugammadex dose on residual neuromuscular blockade will be investigated, therefore patients suffering from various conditions undergoing surgery in general anaesthesia with muscle rel... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002019-13 | Sponsor Protocol Number: 2015/3AITT | Start Date*: 2015-10-12 |
Sponsor Name:University of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy | ||
Full Title: Reversal of deep pipecuronium neuromuscular block using sugammadex: a randomized, double-blind, dosefinding study | ||
Medical condition: The effect of sugammadex dose on deep neuromuscular blockade will be investigated, therefore patients suffering from various conditions undergoing surgery in general anaesthesia with muscle relax... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
